Offer Active Since: 05 Jan, 2012 | Last Updated: 07 Jan, 2012Offer Details:
Debridace Ointment& Spray A randomized, multi-centric study reported that application of papain-urea ointment/spray was significantly more effective than collagenase in reducing non-viable tissue.
US FDA approved papain-urea as early as 1962.
The product is well-tolerated and non-irritating agent.
The ointment contains 5, 21, 700 USP units of activity of papain and 100 mg of urea per gram of ointment. The Drug Controller General of India has approved the product for debridement of wounds.
The ointment is indicated for debridement of necrotic tissue and liquefaction of slough in acute and chronic lesions such as pressure ulcers, varicose and diabetic ulcers, burns, postoperative wounds, pilonidal cyst wounds, carbuncles and miscellaneous traumatic or infected wounds.